InnovaDerma PLC, through its subsidiaries, engages in the research, manufacture, and marketing of clinically proven products in life sciences, beauty, and personal care products in Europe, the United States, Australasia, Asia, and Africa. It offers a range of men's skincare products, including hand and body washes, hand creams, face washes, and face moisturizers under the Charles + Lee name; and tailored solutions under the Leimo name for hair loss comprising shampoos, conditioners, and laser technology treatments developed to combat male and female hair loss, alopecia, thinning hair. The company also provides tanning mousses, tanning gels, tanning oils, primers, moisturizers, and applicators under the Skinny Tan name; cosmetics under the Stevie K name; a medical device for premature ejaculation under the Prolong name; and haircare products for men and women to aid hair regrowth and hair thickening under the Roots name. It markets its products through e-tailers and retailers. The company was incorporated in 2014 and is headquartered in Melbourne, Australia.
Industry, Sector and Symbol
Stock Exchange LON
Industry Specialty Retail
Sub-IndustryN/A
SectorConsumer Cyclical
SymbolLON:IDP
CUSIPN/A
PhoneN/A
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares14,320,000
Market Cap£0.00
Innovaderma (LON:IDP) Frequently Asked Questions
What is Innovaderma's stock symbol?
Innovaderma trades on the London Stock Exchange (LON) under the ticker symbol "IDP."
How were Innovaderma's earnings last quarter?
Innovaderma PLC (LON:IDP) issued its quarterly earnings data on Tuesday, September, 12th. The company reported $6.00 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $4.70 by $1.30. The business earned $8.86 million during the quarter. View Innovaderma's Earnings History.
What price target have analysts set for IDP?
0 Wall Street analysts have issued 12-month price targets for Innovaderma's shares. Their forecasts range from GBX 400 to GBX 400. On average, they expect Innovaderma's share price to reach GBX 400 in the next year. This suggests a possible upside of 252.4% from the stock's current price. View Analyst Price Targets for Innovaderma.
Who are some of Innovaderma's key competitors?
Who are Innovaderma's key executives?
Innovaderma's management team includes the folowing people:
- Mr. Haris Chaudhry FAIM, MAICD, Founder & Exec. Chairman
- Mr. Kieran Callan, CEO & Exec. Director
- Mr. Joseph Bayer FCPA, GAICD, Exec. Director
- Mr. Michael Hume, Gen. Mang. of UK & Europe
How do I buy shares of Innovaderma?
Shares of IDP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Innovaderma's stock price today?
One share of IDP stock can currently be purchased for approximately GBX 113.50.
What is Innovaderma's official website?
MarketBeat Community Rating for Innovaderma (LON IDP)
MarketBeat's community ratings are surveys of what our community members think about Innovaderma and other stocks. Vote "Outperform" if you believe IDP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IDP will underperform the S&P 500 over the long term. You may vote once every thirty days.
